Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC–MS based untargeted metabolomics practitioners

INTRODUCTION The metabolomics quality assurance and quality control consortium (mQACC) evolved from the recognized need for a community-wide consensus on improving and systematizing quality assurance (QA) and quality control (QC) practices for untargeted metabolomics. OBJECTIVES In this work, we sought to identify and share the common and divergent QA and QC practices amongst mQACC members and collaborators who use liquid chromatography-mass spectrometry (LC-MS) in untargeted metabolomics. METHODS All authors voluntarily participated in this collaborative research project by providing the details of and insights into the QA and QC practices used in their laboratories. This sharing was enabled via a six-page questionnaire composed of over 120 questions and comment fields which was developed as part of this work and has proved the basis for ongoing mQACC outreach. RESULTS For QA, many laboratories reported documenting maintenance, calibration and tuning (82%); having established data storage and archival processes (71%); depositing data in public repositories (55%); having standard operating procedures (SOPs) in place for all laboratory processes (68%) and training staff on laboratory processes (55%). For QC, universal practices included using system suitability procedures (100%) and using a robust system of identification (Metabolomics Standards Initiative level 1 identification standards) for at least some of the detected compounds. Most laboratories used QC samples (>86%); used internal standards (91%); used a designated analytical acquisition template with randomized experimental samples (91%); and manually reviewed peak integration following data acquisition (86%). A minority of laboratories included technical replicates of experimental samples in their workflows (36%). CONCLUSIONS Although the 23 contributors were researchers with diverse and international backgrounds from academia, industry and government, they are not necessarily representative of the worldwide pool of practitioners due to the recruitment method for participants and its voluntary nature. However, both questionnaire and the findings presented here have already informed and led other data gathering efforts by mQACC at conferences and other outreach activities and will continue to evolve in order to guide discussions for recommendations of best practices within the community and to establish internationally agreed upon reporting standards. We very much welcome further feedback from readers of this article.

[1]  Richard Nicholas,et al.  Breaking the cycle , 2019, Neurology: Neuroimmunology & Neuroinflammation.

[2]  I. Wilson,et al.  Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  Richard D. Beger,et al.  Towards quality assurance and quality control in untargeted metabolomics studies , 2019, Metabolomics.

[4]  Tariq Shafi,et al.  Serum Metabolites and Cardiac Death in Patients on Hemodialysis. , 2019, Clinical journal of the American Society of Nephrology : CJASN.

[5]  Jiang He,et al.  Novel serum metabolites associate with cognition phenotypes among Bogalusa Heart Study participants , 2019, Aging.

[6]  Thomas Hartung,et al.  Review: Toxicometabolomics , 2013, Journal of applied toxicology : JAT.

[7]  Stephen Burgess,et al.  Assessing the causal association of glycine with risk of cardio-metabolic diseases , 2019, Nature Communications.

[8]  Douglas B. Kell,et al.  Molecular phenotyping of a UK population: defining the human serum metabolome , 2014, Metabolomics.

[9]  David A Fields,et al.  Maternal obesity and the human milk metabolome: associations with infant body composition and postnatal weight gain. , 2019, The American journal of clinical nutrition.

[10]  L. Smirnova,et al.  Metabolomics in toxicology and preclinical research. , 2013, ALTEX.

[11]  Natalia Chueca,et al.  Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study , 2019, BMC Cancer.

[12]  Matej Oresic,et al.  Metabolomics Analytics Workflow for Epidemiological Research: Perspectives from the Consortium of Metabolomics Studies (COMETS) , 2019, Metabolites.

[13]  Denise J. Roe,et al.  Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling , 2019, EBioMedicine.

[14]  Kishu Manghani,et al.  Quality assurance: Importance of systems and standard operating procedures , 2011, Perspectives in clinical research.

[15]  I. Wilson,et al.  Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. , 2007, Journal of proteome research.

[16]  Alexandra Maertens,et al.  t4 Workshop Report , 2017, ALTEX.

[17]  Melanie Waldenberger,et al.  Exposure to disinfection byproducts and risk of type 2 diabetes: a nested case–control study in the HUNT and Lifelines cohorts , 2019, Metabolomics.

[18]  Richard D Beger,et al.  Pharmacometabolomic Pathway Response of Effective Anticancer Agents on Different Diets in Rats with Induced Mammary Tumors , 2019, Metabolites.

[19]  A. Smilde,et al.  Fusion of mass spectrometry-based metabolomics data. , 2005, Analytical chemistry.

[20]  Pierre Baldi,et al.  Time of Exercise Specifies the Impact on Muscle Metabolic Pathways and Systemic Energy Homeostasis. , 2019, Cell metabolism.

[21]  E. Hsiao,et al.  The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet , 2018, Cell.

[22]  John P. Overington,et al.  An atlas of genetic influences on human blood metabolites , 2014, Nature Genetics.

[23]  John C. Earls,et al.  Blood metabolome predicts gut microbiome α-diversity in humans , 2019, Nature Biotechnology.

[24]  Elizabeth T. Cirulli,et al.  Profound Perturbation of the Metabolome in Obesity Is Associated with Health Risk , 2019, Cell metabolism.

[25]  I. Wilson,et al.  A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. , 2006, The Analyst.

[26]  A. Smilde,et al.  Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. , 2006, Analytical chemistry.

[27]  Li Chen,et al.  Sodium Reduction, Metabolomic Profiling, and Cardiovascular Disease Risk in Untreated Black Hypertensives. , 2019, Hypertension.

[28]  Oliver Fiehn,et al.  Preanalytical Processing and Biobanking Procedures of Biological Samples for Metabolomics Research: A White Paper, Community Perspective (for "Precision Medicine and Pharmacometabolomics Task Group"-The Metabolomics Society Initiative). , 2018, Clinical chemistry.

[29]  Joshua D. Knowles,et al.  Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry , 2011, Nature Protocols.

[30]  Inês Laíns,et al.  Human Plasma Metabolomics in Age-Related Macular Degeneration: Meta-Analysis of Two Cohorts , 2019, Metabolites.

[31]  Aleksandar Milosavljevic,et al.  Untargeted Metabolomic Profiling Reveals Multiple Pathway Perturbations and New Clinical Biomarkers in Urea Cycle Disorders , 2019, Genetics in Medicine.

[32]  Erik Schultes,et al.  The FAIR Guiding Principles for scientific data management and stewardship , 2016, Scientific Data.

[33]  Christian Gieger,et al.  Metabolomics Identifies Novel Blood Biomarkers of Pulmonary Function and COPD in the General Population , 2019, Metabolites.

[34]  Nigel W. Hardy,et al.  Proposed minimum reporting standards for chemical analysis , 2007, Metabolomics.

[35]  Pim E G Leonards,et al.  Use cases, best practice and reporting standards for metabolomics in regulatory toxicology , 2019, Nature Communications.

[36]  Nagireddy Putluri,et al.  Liver- and Microbiome-derived Bile Acids Accumulate in Human Breast Tumors and Inhibit Growth and Improve Patient Survival , 2019, Clinical Cancer Research.

[37]  Richard D. Beger,et al.  Quality assurance and quality control processes: summary of a metabolomics community questionnaire , 2017, Metabolomics.

[38]  Zaid Abdo,et al.  Rice bran supplementation modulates growth, microbiota and metabolome in weaning infants: a clinical trial in Nicaragua and Mali , 2019, Scientific Reports.

[39]  Evgeni Levin,et al.  Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time , 2019, Gut.

[40]  Chrysanthi Ainali,et al.  Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02 , 2019, Nature Communications.

[41]  Lawrence J Appel,et al.  The Serum Metabolome Identifies Biomarkers of Dietary Acid Load in 2 Studies of Adults with Chronic Kidney Disease. , 2019, The Journal of nutrition.

[42]  E. Segal,et al.  Potential roles of gut microbiome and metabolites in modulating ALS in mice , 2019, Nature.

[43]  Ying Wang,et al.  Metabolomic markers of healthy dietary patterns in US postmenopausal women. , 2019, The American journal of clinical nutrition.

[44]  David Broadhurst,et al.  The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. , 2012, Bioanalysis.

[45]  Ian D. Wilson,et al.  Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies , 2018, Metabolomics : Official journal of the Metabolomic Society.

[46]  Coral Barbas,et al.  Quality assurance procedures for mass spectrometry untargeted metabolomics. a review , 2018, Journal of pharmaceutical and biomedical analysis.

[47]  Stephen E. Stein,et al.  Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources. , 2013, Analytical chemistry.

[48]  O. D. Rangel-Huerta,et al.  Metabolic profiling in children with autism spectrum disorder with and without mental regression: preliminary results from a cross-sectional case–control study , 2019, Metabolomics.

[49]  Donna M. Muzny,et al.  Leveraging Human Microbiome Features to Diagnose and Stratify Children with Irritable Bowel Syndrome , 2019, The Journal of molecular diagnostics : JMD.

[50]  Jörg Hackermüller,et al.  Framework for the quality assurance of ’omics technologies considering GLP requirements , 2017, Regulatory toxicology and pharmacology : RTP.

[51]  Rima Kaddurah-Daouk,et al.  Untargeted Metabolomic Profiling Identifies Disease-specific Signatures in Food Allergy and Asthma. , 2019, The Journal of allergy and clinical immunology.

[52]  Joshua D. Knowles,et al.  Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. , 2009, Analytical chemistry.